Home » Topics » Disease categories and therapies » Urology

Urology
RSS

New Drug Submission for Ditropan accepted for review in Canada

March 10, 1999

No Comments

Microbially produced 5alpha-reductase inhibitor discovered at Snow Brand

March 9, 1999

No Comments

Licensing opportunity from VUFB: alpha2-adrenoceptor antagonist for BPH and heart failure

Feb. 16, 1999

No Comments

PKC inhibitors designed at Otsuka

Feb. 9, 1999

No Comments

Alza launches Ditropan XL in the U.S.

Feb. 3, 1999

No Comments

Chugai patents 2,3-dihydrobenzofurans with cytoprotective effects

Jan. 27, 1999

No Comments

Oral L-arginine compared to placebo for efficacy in interstitial cystitis

Jan. 25, 1999

No Comments

Therapeutic advantages of paricalcitol further defined

Jan. 25, 1999

No Comments

Rochester Medical files PMA for FemSoft

Jan. 22, 1999

No Comments

Improved treatments for BPH in development at Pfizer

Jan. 22, 1999

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Urology
RSS

New Drug Submission for Ditropan accepted for review in Canada

Microbially produced 5alpha-reductase inhibitor discovered at Snow Brand

Licensing opportunity from VUFB: alpha2-adrenoceptor antagonist for BPH and heart failure

PKC inhibitors designed at Otsuka

Alza launches Ditropan XL in the U.S.

Chugai patents 2,3-dihydrobenzofurans with cytoprotective effects

Oral L-arginine compared to placebo for efficacy in interstitial cystitis

Therapeutic advantages of paricalcitol further defined

Rochester Medical files PMA for FemSoft

Improved treatments for BPH in development at Pfizer

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Urology RSS

Urology
RSS